The Pluripotency Factor Musashi-2 Is a Novel Target for Lung Cancer Therapy

Previously we reported that mithramycin represses multiple pathways critical for stem cell signaling and pluripotency in lung cancer cells. This phenomenon coincided with decreased side population fraction and dramatic dose-dependent growth arrest of lung cancer cells in vitro and in vivo. In the pr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Am Thorac Soc
Autors principals: Zhang, Mary R., Xi, Sichuan, Shukla, Vivek, Hong, Julie A., Chen, Haobin, Xiong, Yin, Ripley, R. Taylor, Hoang, Chuong D., Schrump, David S.
Format: Artigo
Idioma:Inglês
Publicat: American Thoracic Society 2018
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5946505/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201707-608MG
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars